RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodine-refractory differentiated thyroid carcinoma

Por RUAN, MAOMEI, SHEN, YAN, CHEN, LIBO, LI, MINGHUA
Publicado em 2013

Increased (18)F-FDG uptake of heterotopic pancreatitis in the small intestine: A CARE-compliant case report

Por Ruan, Maomei, Liu, Min, Cheng, Lingxiao, Xie, Wenhui, Chen, Libo
Publicado no Medicine (Baltimore) (2016)

HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E

Por Cheng, Lingxiao, Jin, Yuchen, Liu, Min, Ruan, Maomei, Chen, Libo
Publicado no Oncotarget (2017)

Predicting (131)I-avidity of metastases from differentiated thyroid cancer using (18)F-FDG PET/CT in postoperative patients with elevated thyroglobulin

Por Liu, Min, Cheng, Lingxiao, Jin, Yuchen, Ruan, Maomei, Sheng, Shiwei, Chen, Libo
Publicado no Sci Rep (2018)

(99m)Tc-pertechnetate-avid metastases from differentiated thyroid cancer are prone to benefit from (131)I therapy: A prospective observational study

Por Liu, Min, Chai, Li, Luo, Qiong, Ruan, Maomei, Cheng, Lingxiao, Lv, Zhongwei, Chen, Libo
Publicado no Medicine (Baltimore) (2017)